These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3396007)

  • 1. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
    Kim YD; Robinson DY; Tomita JT
    Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the epitope in prostate and breast tumor-associated PR92 antigen.
    Kim YD; Robinson DY; Manderino GL; Tribby II; Tomita JT
    Cancer Res; 1989 May; 49(9):2379-82. PubMed ID: 2468408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostate tissue antigens defined by murine monoclonal antibodies.
    Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
    Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
    Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
    Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human breast tissue-associated antigen detected by a monoclonal antibody.
    Thompson CH; Jones SL; Whitehead RH; McKenzie IF
    J Natl Cancer Inst; 1983 Mar; 70(3):409-19. PubMed ID: 6187962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.
    Frankel AE; Ring DB; Tringale F; Hsieh-Ma ST
    J Biol Response Mod; 1985 Jun; 4(3):273-86. PubMed ID: 4020386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
    Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
    Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
    Iacobelli S; Arnò E; D'Orazio A; Coletti G
    Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide bonding of a human prostate tumor-associated membrane antigen recognized by monoclonal antibody D83.21.
    Starling JJ; Wright GL
    Cancer Res; 1985 Feb; 45(2):804-8. PubMed ID: 2578309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
    Ware JL; Paulson DF; Parks SF; Webb KS
    Cancer Res; 1982 Apr; 42(4):1215-22. PubMed ID: 6174221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to a human prostate antigen.
    Frankel AE; Rouse RV; Wang MC; Chu TM; Herzenberg LA
    Cancer Res; 1982 Sep; 42(9):3714-8. PubMed ID: 6179608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
    Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP
    Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.